vaccines

Evonik is investing 220 million dollar in the Tippecanoe site

Evonik is building a new, highly flexible world-scale production facility for pharmaceutical lipids in the USA. The new facility at Evonik's Tippecanoe site in Lafayette, Indiana, will broadly position the company for future growth in new type mRNA-based therapies beyond Covid-19 vaccines. Construction will begin in...